Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Trypanosoma musculi Infection in Mice Critically Relies on Mannose Receptor-Mediated Arginase Induction by a TbKHC1 Kinesin H Chain Homolog.

Nzoumbou-Boko R, De Muylder G, Semballa S, Lecordier L, Dauchy FA, Gobert AP, Holzmuller P, Lemesre JL, Bras-Gonçalves R, Barnabé C, Courtois P, Daulouède S, Beschin A, Pays E, Vincendeau P.

J Immunol. 2017 Sep 1;199(5):1762-1771. doi: 10.4049/jimmunol.1700179. Epub 2017 Jul 24.

PMID:
28739879
2.

Efficacy of indefinite chronic oral antimicrobial suppression for prosthetic joint infection in the elderly: a comparative study.

Prendki V, Sergent P, Barrelet A, Oziol E, Beretti E, Berlioz-Thibal M, Bouchand F, Dauchy FA, Forestier E, Gavazzi G, Ronde-Oustau C, Stirnemann J, Dinh A.

Int J Infect Dis. 2017 Jul;60:57-60. doi: 10.1016/j.ijid.2017.05.008. Epub 2017 May 16.

3.

Absence of Decline of Kidney Function in Human Immunodeficiency Virus-Infected Patients Under Routine Clinical Management.

Boucquemont J, Lawson-Ayayi S, Rigothier C, Bonnet F, Proust-Lima C, Neau D, Greib C, Miremont-Salamé G, Dabis F, Dupon M, Dauchy FA; for ANRS C03 Aquitaine Cohort Study Group.

Nephron. 2017;136(3):211-220. doi: 10.1159/000467400. Epub 2017 Apr 26.

PMID:
28445881
4.

Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study.

Prendki V, Ferry T, Sergent P, Oziol E, Forestier E, Fraisse T, Tounes S, Ansart S, Gaillat J, Bayle S, Ruyer O, Borlot F, Le Falher G, Simorre B, Dauchy FA, Greffe S, Bauer T, Bell EN, Martha B, Martinot M, Froidure M, Buisson M, Waldner A, Lemaire X, Bosseray A, Maillet M, Charvet V, Barrelet A, Wyplosz B, Noaillon M, Denes E, Beretti E, Berlioz-Thibal M, Meyssonnier V, Fourniols E, Tliba L, Eden A, Jean M, Arvieux C, Guignery-Kadri K, Ronde-Oustau C, Hansmann Y, Belkacem A, Bouchand F, Gavazzi G, Herrmann F, Stirnemann J, Dinh A.

Eur J Clin Microbiol Infect Dis. 2017 Apr 4. doi: 10.1007/s10096-017-2971-2. [Epub ahead of print]

PMID:
28378243
5.

Activation, senescence and inflammation markers in HIV patients: association with renal function.

Ozanne A, Duffau P, Dauchy FA, Rigothier C, Terrien C, Lazaro E, Cazanave C, Lawson-Ayayi S, Bonnet F, Blanco P, Wittkop L, Pellegrin I; CIADIS sub-study in the ANRS CO3 Aquitaine cohort study group.

AIDS. 2017 May 15;31(8):1119-1128. doi: 10.1097/QAD.0000000000001461.

PMID:
28328797
6.

Nontuberculous Mycobacterial Infections in a French Hospital: A 12-Year Retrospective Study.

Blanc P, Dutronc H, Peuchant O, Dauchy FA, Cazanave C, Neau D, Wirth G, Pellegrin JL, Morlat P, Mercié P, Tunon-de-Lara JM, Doutre MS, Pélissier P, Dupon M.

PLoS One. 2016 Dec 13;11(12):e0168290. doi: 10.1371/journal.pone.0168290. eCollection 2016.

7.

Efficacy of debridement, antibiotic therapy and implant retention within three months during postoperative instrumented spine infections.

Wille H, Dauchy FA, Desclaux A, Dutronc H, Vareil MO, Dubois V, Vital JM, Dupon M.

Infect Dis (Lond). 2017 Apr;49(4):261-267. doi: 10.1080/23744235.2016.1255351. Epub 2016 Nov 21.

PMID:
27866452
8.

Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.

Dauchy FA, Bonhivers M, Landrein N, Dacheux D, Courtois P, Lauruol F, Daulouède S, Vincendeau P, Robinson DR.

PLoS Negl Trop Dis. 2016 Nov 17;10(11):e0005125. doi: 10.1371/journal.pntd.0005125. eCollection 2016 Nov. Erratum in: PLoS Negl Trop Dis. 2017 Jan 31;11(1):e0005328.

9.

Spondylodiscitis and bacteremia due to Staphylococcus hyicus in an immunocompetent man.

Foissac M, Lekaditi M, Loutfi B, Ehrhart A, Dauchy FA.

Germs. 2016 Sep 1;6(3):106-10. doi: 10.11599/germs.2016.1097. eCollection 2016 Sep.

10.

Interest of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography for the diagnosis of relapse in patients with spinal infection: a prospective study.

Dauchy FA, Dutertre A, Lawson-Ayayi S, de Clermont-Gallerande H, Fournier C, Zanotti-Fregonara P, Dutronc H, Vital JM, Dupon M, Fernandez P.

Clin Microbiol Infect. 2016 May;22(5):438-43. doi: 10.1016/j.cmi.2015.12.028. Epub 2016 Jan 21.

11.

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.

Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study.

Lancet HIV. 2016 Jan;3(1):e23-32. doi: 10.1016/S2352-3018(15)00211-8. Epub 2015 Nov 17.

PMID:
26762990
12.

Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients.

Duffau P, Wittkop L, Lazaro E, le Marec F, Cognet C, Blanco P, Moreau JF, Dauchy FA, Cazanave C, Vandenhende MA, Bonnet F, Thiebaut R, Pellegrin I; ANRS CO3 Aquitaine Cohort Study Group.

AIDS. 2015 Oct 23;29(16):2099-108. doi: 10.1097/QAD.0000000000000807.

PMID:
26544576
13.

Diabetes and cognitive decline in a French cohort of patients infected with HIV-1.

Dufouil C, Richert L, Thiébaut R, Bruyand M, Amieva H, Dauchy FA, Dartigues JF, Neau D, Morlat P, Dehail P, Dabis F, Bonnet F, Chêne G; ANRS CO3 Aquitaine Study Group.

Neurology. 2015 Sep 22;85(12):1065-73. doi: 10.1212/WNL.0000000000001815. Epub 2015 Jul 8.

14.

Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.

Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C; D:A:D study group.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):568-77. doi: 10.1097/QAI.0000000000000523.

PMID:
25763785
15.

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA.

Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6.

16.

Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults.

Marzolini C, Sabin C, Raffi F, Siccardi M, Mussini C, Launay O, Burger D, Roca B, Fehr J, Bonora S, Mocroft A, Obel N, Dauchy FA, Zangerle R, Gogos C, Gianotti N, Ammassari A, Torti C, Ghosn J, Chêne G, Grarup J, Battegay M; Efavirenz, Obesity Project Team on behalf of Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

AIDS. 2015 Jan 14;29(2):193-200. doi: 10.1097/QAD.0000000000000530.

17.

Severe morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine Cohort.

Hessamfar M, Colin C, Bruyand M, Decoin M, Bonnet F, Mercié P, Neau D, Cazanave C, Pellegrin JL, Dabis F, Morlat P, Chêne G; GECSA study group.

PLoS One. 2014 Jul 30;9(7):e102671. doi: 10.1371/journal.pone.0102671. eCollection 2014.

18.

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.

Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte Ad, Phillips AN, Sabin CA, Lundgren JD; D:A:D Study Group.

Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8.

PMID:
25042234
19.

AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: hospital-based cohort studies.

Luz PM, Bruyand M, Ribeiro S, Bonnet F, Moreira RI, Hessamfar M, Campos DP, Greib C, Cazanave C, Veloso VG, Dabis F, Grinsztejn B, Chêne G; IPEC/FIOCRUZ Cohort and the Aquitaine ANRS C03 Study Group.

BMC Infect Dis. 2014 May 21;14:278. doi: 10.1186/1471-2334-14-278.

20.

Prognostic factors of calcaneal osteomyelitis.

Merlet A, Cazanave C, Dauchy FA, Dutronc H, Casoli V, Chauveaux D, De Barbeyrac B, Dupon M.

Scand J Infect Dis. 2014 Aug;46(8):555-60. doi: 10.3109/00365548.2014.914241. Epub 2014 May 20.

PMID:
24840344

Supplemental Content

Loading ...
Support Center